Use of proton pump inhibitors in chronic liver diseases.
作者信息
Li Darrick K, Chung Raymond T
机构信息
Department of Gastroenterology Massachusetts General Hospital Boston MA.
出版信息
Clin Liver Dis (Hoboken). 2018 Jan 2;10(6):148-151. doi: 10.1002/cld.678. eCollection 2017 Dec.
Abstract
摘要
相似文献
1
Use of proton pump inhibitors in chronic liver diseases.质子泵抑制剂在慢性肝病中的应用。
Clin Liver Dis (Hoboken). 2018 Jan 2;10(6):148-151. doi: 10.1002/cld.678. eCollection 2017 Dec.
2
Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.质子泵抑制剂与非肝硬化的慢性丙型肝炎感染患者的肝硬化、肝功能失代偿和肝细胞癌的加速发展相关：来自 ERCHIVES 的结果。
Aliment Pharmacol Ther. 2018 Jan;47(2):246-258. doi: 10.1111/apt.14391. Epub 2017 Nov 3.
3
Correlation between proton pump inhibitors and risk of pyogenic liver abscess.质子泵抑制剂与肝脓肿发生风险之间的相关性
Eur J Clin Pharmacol. 2017 Aug;73(8):1019-1025. doi: 10.1007/s00228-017-2256-9. Epub 2017 Apr 22.
4
Endoscopic and histopathologic gastric changes in chronic users of proton-pump inhibitors.质子泵抑制剂长期使用者的内镜及组织病理学胃部变化
Arq Gastroenterol. 2015 Jan-Mar;52(1):59-64. doi: 10.1590/S0004-28032015000100013.
5
Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients.慢性肾脏病（CKD）患者比非 CKD 患者暴露于更多的质子泵抑制剂（PPI）。
PLoS One. 2018 Sep 13;13(9):e0203878. doi: 10.1371/journal.pone.0203878. eCollection 2018.
6
Proton pump inhibitors--differences emerge in hepatic metabolism.
Dig Liver Dis. 2002 Jul;34(7):461-7. doi: 10.1016/s1590-8658(02)80102-5.
7
Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy.在需要长期抗炎治疗的患者中合理使用非甾体抗炎药、环氧化酶-2特异性抑制剂和质子泵抑制剂的指南。
Aliment Pharmacol Ther. 2004 Jan 15;19(2):197-208. doi: 10.1111/j.0269-2813.2004.01834.x.
8
Multimorbidities and Overprescription of Proton Pump Inhibitors in Older Patients.老年患者的多种疾病与质子泵抑制剂的过度处方
PLoS One. 2015 Nov 4;10(11):e0141779. doi: 10.1371/journal.pone.0141779. eCollection 2015.
9
Effect of the Prophylactic Use of Proton-Pump Inhibitors on the Pattern of Gastrointestinal Symptoms in Patients Late After Kidney Transplant.预防性使用质子泵抑制剂对肾移植术后晚期患者胃肠道症状模式的影响
Exp Clin Transplant. 2016 Oct;14(5):503-510. doi: 10.6002/ect.2015.0252. Epub 2016 May 17.
10
Proton pump inhibitors in children: a review.儿童质子泵抑制剂综述
Dig Liver Dis. 2003 Oct;35(10):738-46. doi: 10.1016/s1590-8658(03)00420-1.
引用本文的文献
1
Use of Proton Pump Inhibitors Among Patients With Alcohol-Related Cirrhosis-A Danish Nationwide Cohort Study.酒精性肝硬化患者中质子泵抑制剂的使用——一项丹麦全国队列研究
Liver Int. 2025 Apr;45(4):e70061. doi: 10.1111/liv.70061.
2
Proton Pump Inhibitors in Patients with Cirrhosis: Pharmacokinetics, Benefits and Drawbacks.肝硬化患者的质子泵抑制剂：药代动力学、获益和弊端。
Curr Gastroenterol Rep. 2024 Dec;26(12):323-334. doi: 10.1007/s11894-024-00943-7. Epub 2024 Aug 21.
3
Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.质子泵抑制剂增加肝硬化患者死亡、失代偿和感染的长期风险：一项荟萃分析。
Dig Dis Sci. 2024 Jan;69(1):289-297. doi: 10.1007/s10620-023-08150-6. Epub 2023 Nov 15.
4
Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship.质子泵抑制剂优化使用指南：PPI 管理。
Indian J Gastroenterol. 2023 Oct;42(5):601-628. doi: 10.1007/s12664-023-01428-7. Epub 2023 Sep 12.
5
Effects of postoperative use of proton pump inhibitors on gastrointestinal bleeding after endoscopic variceal treatment during hospitalization.住院期间内镜下静脉曲张治疗后使用质子泵抑制剂对胃肠道出血的影响。
World J Gastrointest Surg. 2023 Jan 27;15(1):82-93. doi: 10.4240/wjgs.v15.i1.82.
6
Effect of aluminum phosphate gel on prevention of early rebleeding after ligation of esophageal variceal hemorrhage.磷酸铝凝胶对预防食管静脉曲张破裂出血结扎术后早期再出血的作用。
World J Gastrointest Surg. 2021 Dec 27;13(12):1651-1659. doi: 10.4240/wjgs.v13.i12.1651.
7
Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis.质子泵抑制剂与慢性肝病患者肝癌风险和死亡率的关系：系统评价和荟萃分析。
Eur J Clin Pharmacol. 2020 Jun;76(6):851-866. doi: 10.1007/s00228-020-02854-8. Epub 2020 Mar 14.
本文引用的文献
1
The impact of proton pump inhibitor therapy on patients with liver disease.质子泵抑制剂治疗对肝病患者的影响。
Aliment Pharmacol Ther. 2016 Dec;44(11-12):1213-1223. doi: 10.1111/apt.13827. Epub 2016 Oct 23.
2
Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.质子泵抑制剂增加肝硬化患者肝性脑病风险：一项基于人群的研究。
Gastroenterology. 2017 Jan;152(1):134-141. doi: 10.1053/j.gastro.2016.09.007. Epub 2016 Sep 14.
3
Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.质子泵抑制剂作为肝硬化伴腹水患者肝性脑病和自发性细菌性腹膜炎的危险因素。
Hepatology. 2016 Oct;64(4):1265-72. doi: 10.1002/hep.28737. Epub 2016 Aug 24.
4
Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: A meta-analysis.质子泵抑制剂治疗及其与自发性细菌性腹膜炎发病率和死亡率的关联：一项荟萃分析。
Dig Liver Dis. 2016 Apr;48(4):353-9. doi: 10.1016/j.dld.2015.12.009. Epub 2015 Dec 29.
5
Proton pump inhibitors alter the composition of the gut microbiota.质子泵抑制剂会改变肠道微生物群的组成。
Gut. 2016 May;65(5):749-56. doi: 10.1136/gutjnl-2015-310861. Epub 2015 Dec 30.
6
Proton pump inhibitors affect the gut microbiome.质子泵抑制剂会影响肠道微生物群。
Gut. 2016 May;65(5):740-8. doi: 10.1136/gutjnl-2015-310376. Epub 2015 Dec 9.
7
Systematic review and meta-analysis of the possible association between pharmacological gastric acid suppression and spontaneous bacterial peritonitis.药物性胃酸抑制与自发性细菌性腹膜炎之间可能关联的系统评价和荟萃分析
Eur J Gastroenterol Hepatol. 2015 Nov;27(11):1327-36. doi: 10.1097/MEG.0000000000000448.
8
Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis.质子泵抑制剂的使用与肝硬化患者自发性细菌性腹膜炎的风险：一项系统评价和荟萃分析。
Genet Mol Res. 2015 Jul 6;14(3):7490-501. doi: 10.4238/2015.July.3.25.
9
Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?在肝脏疾病中，肠道炎症是否将微生物群失调与肠道屏障功能障碍联系起来？
Expert Rev Gastroenterol Hepatol. 2015;9(8):1069-76. doi: 10.1586/17474124.2015.1057122. Epub 2015 Jun 18.
10
Use of proton pump inhibitors in the management of gastroesophageal varices: a systematic review.质子泵抑制剂在食管胃静脉曲张管理中的应用：一项系统评价
Ann Pharmacother. 2015 Feb;49(2):207-19. doi: 10.1177/1060028014559244.
Zotero 插件